Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
ASC or Extreme Reach?
-
A few of our clients on the consumer side (DTC, OTC) have been asking us about an Extreme Reach pre-clearance review instead of ASC. Can you confirm if they are in fact interchangable? Wanted to make sure that PAAB would recognise both.
Please note that this is not a PAAB Code issue per se. Extreme Reach is MIJO in the following Health Canada policy document:
Health Canada provides a list of preclearance agencies on their site:
-
Please note that this is not a PAAB Code issue per se. Extreme Reach is MIJO in the following Health Canada policy document:
Health Canada provides a list of preclearance agencies on their site:
-
@jennifer-carroll Thanks for the clarification Jen. Just to confirm, given that they are both recognised by Health Canada on their list of preclearence Agencies we can use either body. Have a great weekend.
DTC for OTCs is out of the PAAB Code’s scope. We do not comment on, or endorse, any particular agency in the DTC space for OTCs. The PAAB encourages preclearance of DTC/OTC materials by a Health Canada recognized agency.
